Systematic approach: An evidence management strategy for better decision-making

Journal of Evidence-Based Medicine

Volumn 6, Issue 2, 2013, Pages 109-114

  Squara, Pierre ^a  

^a CERIC   (France)

Author keywords

Computerization; Decision making; Evidence based medicine; Modelization; Systematic approach

Indexed keywords

EPLERENONE;

ARTICLE; BLOOD PRESSURE; CORONARY ARTERY BLOOD FLOW; DISEASE CLASSIFICATION; EVIDENCE BASED MEDICINE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FUNCTION; MEDICAL DECISION MAKING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPRODUCIBILITY;

COMPUTERIZATION; DECISION-MAKING; EVIDENCE-BASED MEDICINE; MODELIZATION; SYSTEMATIC APPROACH;

DECISION MAKING; EVIDENCE-BASED MEDICINE; HUMANS; MINERALOCORTICOID RECEPTOR ANTAGONISTS; MYOCARDIAL INFARCTION; REPRODUCIBILITY OF RESULTS; SPIRONOLACTONE; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84884395264     PISSN: 17565383     EISSN: 17565391     Source Type: Journal    
DOI: 10.1111/jebm.12037     Document Type: Article

References (26)

1. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ; 1996; 312(7023): 71.
2. Tonelli MR. Integrating evidence into clinical practice: an alternative to evidence-based approaches. J Eval Clin Pract 2006; 12(3): 248-56.
3. Landefeld CS, Steinman MA. The Neurontin legacy-marketing through misinformation and manipulation. N Engl J Med 2009; 360(2): 103-6.
4. Rothman D, McDonald W, Berkowitz C, Chimonas S, DeAngelis C, Hale R, et al. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA 2009; 301(13): 1367-72.
5. Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995; 345(8953): 840-2.
6. Wiener N. Cybernetics of Control and Communication in the Animal and the Machine. MIT Press and John Wiley. 1961.
7. Squara P, Journois D, Formela F, Dhainaut J, Sollet JP, Bleichner G. Value of elementary, calculated and modeled hemodynamic variables. J Crit Care 1994; 9(4): 223-35.
8. Huang A, Roy DA, Summers RM, Franaszek M, Petrick N, Choi JR, et al. Teniae coli-based circumferential localization system for CT colonography: feasibility study. Radiology 2007; 243(2): 551-60.
9. Benenson Y, Gil B, Ben-Dor U, Adar R, Shapiro E. An autonomous molecular computer for logical control of gene expression. Nature 2004; 429(6990): 423-9.
10. Squara P, Schremmer B. Computer assistance for hemodynamic evaluation. In Computer assistance for hemodynamic evaluation, Dhainault J, Payen D (eds). Springer Verlag: Berlin. 1991.
11. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348(14): 1309-21.
12. Yamamoto T, Yasutake M, Takagi H, Akutsu K, Fujita N, Kasagami Y, et al. Impact of the revised criteria for acute myocardial infarction using cardiac troponins in a Japanese population with acute coronary syndromes. Circ J 2005; 69(7): 774-9.
13. Galema TW, Geleijnse ML, Yap SC, van Domburg RT, Biagini E, Vletter WB, et al. Assessment of left ventricular ejection fraction after myocardial infarction using contrast echocardiography. Eur J Echocardiogr 2008; 9(2): 250-4.
14. Suzuki G, Morita H, Mishima T, Sharov VG, Todor A, Tanhehco EJ, et al. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation 2002; 106(23): 2967-72.
15. De Mello WC. Beneficial effect of eplerenone on cardiac remodelling and electrical properties of the failing heart. J Renin Angiotensin Aldosterone Syst 2006; 7(1): 40-6.
16. Joffe HV, Kwong RY, Gerhard-Herman MD, Rice C, Feldman K, Adler GK. Beneficial Effects of Eplerenone Versus Hydrochlorothiazide on Coronary Circulatory Function in Patients with Diabetes Mellitus. J Clin Endocrinol Metab 2007; 92(7): 2552-8.
17. Iraqi W, Rossignol P, Angioi M, Fay R, Nuee J, Ketelslegers J, et al. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study. Circulation 2009; 119(18): 2471-9.
18. Macdonald J, Kennedy N, Struthers A. Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment. Heart 2004; 90(7): 765-70.
19. Rousseau MF, Gurné O, Duprez D, Van Mieghem W, Robert A, Ahn S, et al. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy. J Am Coll Cardiol 2002; 40(9): 1596-601.
20. Michea L, Delpiano AM, Hitschfeld C, Lobos L, Lavandero S, Marusic ET. Eplerenone blocks nongenomic effects of aldosterone on the Na+/H +exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels. Endocrinology 2005; 146(3): 973-80.
21. Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res 2007; 101(3): 234-47.
22. Butter C, Rastogi S, Minden H, Meyhofer J, Burkhoff D, Sabbah H. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol 2008; 51(18): 1784-9.
23. Weir R, Mark P, Petrie C, Clements S, Steedman T, Ford I, et al. Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect?. Am Heart J 2009; 157(6): 1088-96.
24. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004; 43(3): 1459-65.
25. ONTARGET investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59.
26. Squara P, Fourquet E, Jacquet L, Broccard A, Uhlig T, Rhodes A, et al. A computer program for interpreting pulmonary artery catheterization data: results of the European HEMODYN Resident Study. Intensive Care Med 2003; 29(5): 735-41.